Coronavirus disease-19 is associated with decreased treatment access and worsened outcomes in malignant brain tumor patients
- PMID: 37680935
- PMCID: PMC10481862
- DOI: 10.25259/SNI_440_2023
Coronavirus disease-19 is associated with decreased treatment access and worsened outcomes in malignant brain tumor patients
Abstract
Background: The global coronavirus disease-19 (COVID-19) pandemic has resulted in procedural delays around the world; however, timely and aggressive surgical resection for malignant brain tumor patients is essential for outcome optimization. To investigate the association between COVID-19 and outcomes of these patients, we queried the 2020 National Inpatient Sample (NIS) for differences in rates of surgical resection, time to surgery, mortality, and discharge disposition between patients with and without confirmed COVID-19 infection.
Methods: Patient data were taken from the NIS from April 2020 to December 2020. COVID-19 diagnosis was determined with the International Classification of Diseases, Tenth Revision, Clinical Modification code U07.1.
Results: A total of 30,671 malignant brain tumor patients met inclusion criteria and 738 (2.4%) patients had a confirmed COVID-19 diagnosis. COVID-19-positive patients had lower likelihood of receiving surgery (Odds ratio [OR] 0.43, 95% confidence interval [CI] 0.29-0.63, P < 0.0001), increased likelihood of mortality (OR 2.18, 95% CI 1.78-2.66, P < 0.0001), and increased likelihood of non-routine discharge (OR 1.25, 95% CI 1.13-1.39, P < 0.0001). Notably, COVID patients receiving surgery were not associated with surgical delay (P = 0.17).
Conclusion: COVID-19 infection was associated with worse patient outcome in malignant brain tumor patients, including decreased likelihood of receiving surgery, increased likelihood of mortality, and increased likelihood of non-routine discharge. Our study highlights the need to balance the risks and benefits of delaying surgery for malignant brain tumor patients with COVID-19. Although the COVID-19 pandemic is no longer a public health emergency, understanding the pandemic's impact on outcome provides important insight in effective triage for these patients in the situations where resources are limited.
Keywords: Brain tumor; Coronavirus; Coronavirus disease-19; Malignant; National inpatient sample.
Copyright: © 2023 Surgical Neurology International.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Increased time to surgery and worse perioperative outcome in benign brain tumor patients with COVID-19.J Clin Neurosci. 2023 Nov;117:20-26. doi: 10.1016/j.jocn.2023.09.010. Epub 2023 Sep 21. J Clin Neurosci. 2023. PMID: 37740998 Free PMC article.
-
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058. JAMA Netw Open. 2020. PMID: 33301018 Free PMC article.
-
The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis.J Neurosurg. 2017 Feb;126(2):537-547. doi: 10.3171/2015.12.JNS151107. Epub 2016 Apr 8. J Neurosurg. 2017. PMID: 27058205
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4. PMID: 33044747 Updated.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
Cited by
-
Increased time to surgery and worse perioperative outcome in benign brain tumor patients with COVID-19.J Clin Neurosci. 2023 Nov;117:20-26. doi: 10.1016/j.jocn.2023.09.010. Epub 2023 Sep 21. J Clin Neurosci. 2023. PMID: 37740998 Free PMC article.
-
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.Adv Ther. 2025 Feb;42(2):666-719. doi: 10.1007/s12325-024-03043-0. Epub 2024 Dec 16. Adv Ther. 2025. PMID: 39680311 Free PMC article. Review.
References
-
- ASA and APSF Joint Statement on Elective Surgery/Procedures and Anesthesia for Patients after COVID-19 Infection. 2022. Available from: https://www.apsf.org/wp-content/uploads/news-updates/2022/ASA-APSF-Joint... [Last accessed on 2023 Mar 07]
-
- Azar KM, Shen Z, Romanelli RJ, Lockhart SH, Smits K, Robinson S, et al. Disparities in outcomes among COVID-19 patients in a large health care system in California. Health Aff (Millwood) 2020;39:1253–62. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous